HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Naschitz, J Articles by Rosner, I Search for Related Content PubMed PubMed Citation Articles by Naschitz, J Articles by Rosner, I

Midodrine treatment for chronic fatigue syndrome

¹ Department of Internal Medicine A, Bnai Zion Medical Center and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
² Department of Rheumatology, Bnai Zion Medical Center and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Correspondence to:
Correspondence to:
Dr Jochanan E Naschitz
Department of Internal Medicine A, Bnai Zion Medical Center, Haifa 31048, PO Box 4940, Israel; Naschitz{at}tx.technion.ac.il

The long term results of midodrine treatment in a patient having debilitating chronic fatigue syndrome (CFS) are reported. Midodrine treatment, directed at the autonomic nervous system, resulted in correction of the dysautonomia followed by improvement of fatigue. This finding is consistent with the hypothesis that dysautonomia plays a major part in the pathophysiology of CFS and that therapies directed at the autonomic nervous system may be effective in the treatment of CFS.

Keywords: chronic fatigue syndrome; dysautonomia; tilt test; midodrine

Abbreviations: CFS, chronic fatigue syndrome; HIS, haemodynamic instability score

This article has been cited by other articles:

				H. Legge, M. Norton, and J. L. Newton Fatigue is significant in vasovagal syncope and is associated with autonomic symptoms Europace, September 1, 2008; 10(9): 1095 - 1101. [Abstract] [Full Text] [PDF]

				E. Bruera, B. El Osta, V. Valero, L. C. Driver, B.-L. Pei, L. Shen, V. A. Poulter, and J. L. Palmer Donepezil for Cancer Fatigue: A Double-Blind, Randomized, Placebo-Controlled Trial J. Clin. Oncol., August 10, 2007; 25(23): 3475 - 3481. [Abstract] [Full Text] [PDF]